/ Side by side
Cagrilintide vs Pramlintide
A neutral, side-by-side look at Cagrilintide and Pramlintide: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Cagrilintide
Cagri · NN9838
Full profile →Pramlintide
Symlin · SymlinPen
Full profile →| Attribute | Cagrilintide | Pramlintide |
|---|---|---|
| Category | GLP-1 / Metabolic | GLP-1 / Metabolic |
| Half-life | ~7 days | ~48 min, subcutaneous |
| Common vial | 5, 10 mg | Varies |
| Reference | Verified | Verified |
What is Cagrilintide?
A long-acting acylated amylin analog engineered to resist aggregation and bind albumin, studied in trials for appetite regulation and weight management, often alongside a GLP-1 agonist. Investigational.
Sources
- Kruse et al., J Med Chem 2021
- Phase 1 PK (once-weekly dosing)
What is Pramlintide?
A synthetic analog of human amylin, approved as an adjunct to mealtime insulin in type 1 and type 2 diabetes. Amylin is co-secreted with insulin, which is the pathway cagrilintide and petrelintide also target.
Sources
- FDA label: SymlinPen (NDA 021332)
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.